CAS No. 2630904-45-7
Batch:
Purity:99.05
Chemical Structure
Check the
MRTX1719 (Navlimetostat)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 2-[4-[4-(aminomethyl)-1-oxo-2H-phthalazin-6-yl]-1-methylpyrazol-5-yl]-4-chloro-6-cyclopropyloxy-3-fluorobenzonitrile | |
|---|---|---|
| CAS Number | 2630904-45-7 | |
| Molecular Formula |
C23H18ClFN6O2 |
|
| Molecular Weight (MW) | 464.88 | |
| InChIKey | BZKIOORWZAXIBA-UHFFFAOYSA-N |
MRTX1719 (Navlimetostat) is a potent, selective, MTA-cooperative inhibitor of the PRMT5•MTA complex. By binding selectively to the PRMT5•MTA complex present in MTAP-deleted cancer cells, MRTX1719 suppresses symmetric dimethylarginine (SDMA) protein modification, exhibiting over 70-fold selective inhibition of PRMT5 activity and cell viability in MTAP-deficient cells relative to MTAP wild-type cells. This selective PRMT5 inhibition induces synthetic lethality, driving cell cycle arrest and suppressing tumor growth in MTAP-null cancers. [1][2]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
93 mg/mL
(200.05 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 93 mg/mL |
| Water | Insoluble |
| DMSO |
93 mg/mL
(200.05 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 93 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- MRTX1719 (Navlimetostat) Clinical Trials
- MRTX1719 (Navlimetostat) Solubility in DMSO
- MRTX1719 (Navlimetostat) Stock Solution
- MRTX1719 (Navlimetostat) Storage
- MRTX1719 (Navlimetostat) Stability
- MRTX1719 (Navlimetostat) Molecular Weight
- MRTX1719 (Navlimetostat) Chemical Structure (2D and 3D)
- MRTX1719 (Navlimetostat) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.